These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3640590

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M, Rouse M, Henry N, Wilson W.
    Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
    [Abstract] [Full Text] [Related]

  • 3. Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Kaatz GW, Barriere SL, Schaberg DR, Fekety R.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):527-30. PubMed ID: 3649202
    [Abstract] [Full Text] [Related]

  • 4. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.
    Antimicrob Agents Chemother; 1989 Apr; 33(4):519-21. PubMed ID: 2499251
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
    Chambers HF, Xiang Q, Liu, Chow LL, Hackbarth C.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
    [Abstract] [Full Text] [Related]

  • 7. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
    Rouse MS, Wilcox RM, Henry NK, Steckelberg JM, Wilson WR.
    Antimicrob Agents Chemother; 1990 Feb; 34(2):273-6. PubMed ID: 2327776
    [Abstract] [Full Text] [Related]

  • 8. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA.
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [Abstract] [Full Text] [Related]

  • 9. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
    Entenza JM, Que YA, Vouillamoz J, Glauser MP, Moreillon P.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
    [Abstract] [Full Text] [Related]

  • 10. CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Lamp KC, Bailey EM, Rybak MJ.
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1192-7. PubMed ID: 1329613
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
    Entenza JM, Vouillamoz J, Glauser MP, Moreillon P.
    Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
    Sullam PM, Täuber MG, Hackbarth CJ, Chambers HF, Scott KG, Sande MA.
    Antimicrob Agents Chemother; 1985 May; 27(5):685-7. PubMed ID: 3860185
    [Abstract] [Full Text] [Related]

  • 14. Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Gilbert M, Boscia JA, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1986 Mar; 29(3):461-3. PubMed ID: 3459391
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.
    Voorn GP, Thompson J, Goessens WH, Schmal-Bauer WC, Broeders PH, Michel MF.
    J Antimicrob Chemother; 1994 Apr; 33(4):785-94. PubMed ID: 8056697
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.
    Berry AJ, Johnston JL, Archer GL.
    Antimicrob Agents Chemother; 1986 May; 29(5):748-52. PubMed ID: 3460523
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.
    Antimicrob Agents Chemother; 1990 Feb; 34(2):257-60. PubMed ID: 2327773
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
    Entenza JM, Vouillamoz J, Glauser MP, Moreillon P.
    Antimicrob Agents Chemother; 1999 Jan; 43(1):77-84. PubMed ID: 9869569
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.